Thomas Pap

Summary

Country: Germany

Publications

  1. ncbi Cyclophilins in rheumatoid arthritis--stepping into an undiscovered country?
    Thomas Pap
    Division of Molecular Medicine of Musculoskeletal Tissue, Department of Orthopaedic Surgery, University Hospital of Munster, Domagkstrasse 3, D-48129 Munster, Germany
    Clin Immunol 116:199-201. 2005
  2. ncbi Direct interaction of immunoglobulins with synovial fibroblasts: a missing link in the pathogenesis of rheumatoid arthritis?
    Thomas Pap
    Division of Molecular Medicine of Musculoskeletal Tissue, , Germany
    Arthritis Res Ther 7:44-6. 2005
  3. ncbi The role of synovial fibroblasts in mediating joint destruction in rheumatoid arthritis
    Ingmar Meinecke
    Division of Experimental Rheumatology, University Hospital Magdeburg, Leipziger Str. 44, D-39120 Magdeburg, Germany
    Curr Pharm Des 11:563-8. 2005
  4. ncbi Gene transfer of tissue inhibitor of metalloproteinases-3 reverses the inhibitory effects of TNF-alpha on Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts
    Andreas Drynda
    Division of Experimental Rheumatology and Orthopedics, Institute of Microbiology, Otto von Guericke University, Magdeburg, Germany
    J Immunol 174:6524-31. 2005
  5. ncbi Retroviral gene transfer of an antisense construct against membrane type 1 matrix metalloproteinase reduces the invasiveness of rheumatoid arthritis synovial fibroblasts
    Edita Rutkauskaite
    Otto-von-Guericke-University, Magdeburg, Germany
    Arthritis Rheum 52:2010-4. 2005
  6. ncbi MAPK signalling in rheumatoid joint destruction: can we unravel the puzzle?
    Lars-Henrik Meyer
    Division of Molecular Medicine of Musculoskeletal Tissue, Department of Orthopaedics, University Hospital of Munster, Munster, Germany
    Arthritis Res Ther 7:177-8. 2005
  7. ncbi The role of mesenchymal cells in the pathophysiology of inflammatory arthritis
    Lars-Henrik Meyer
    Division of Molecular Medicine of Musculoskeletal Tissue, Department of Orthopedics, University Hospital Muenster, Domagkstrasse 3, D-48149 Munster, Germany
    Best Pract Res Clin Rheumatol 20:969-81. 2006
  8. ncbi Attachment to laminin-111 facilitates transforming growth factor beta-induced expression of matrix metalloproteinase-3 in synovial fibroblasts
    Maik Hoberg
    Department of Orthopedic Surgery, CRONA University Hospital, Tuebingen, Germany
    Ann Rheum Dis 66:446-51. 2007
  9. ncbi Hepatocyte growth factor induction of macrophage chemoattractant protein-1 and osteophyte-inducing factors in osteoarthritis
    Berno Dankbar
    Department of Orthopaedics, University Hospital of Muenster, Domagkstrasse 3, D 48149 Muenster, Germany
    J Orthop Res 25:569-77. 2007
  10. ncbi Modification of nuclear PML protein by SUMO-1 regulates Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts
    Ingmar Meinecke
    Department of Traumatology and Reconstructive Surgery, University Hospital Munster, D 48149 Munster, Germany
    Proc Natl Acad Sci U S A 104:5073-8. 2007

Collaborators

  • U Muller-Ladner
  • R E Gay
  • Jörg Schedel
  • Georg Schett
  • J Smolen
  • L C Huber
  • Caroline Ospelt
  • C A Seemayer
  • Maximilian Rudert
  • R Lobmann
  • T W J Huizinga
  • Steffen Gay
  • Ingmar Meinecke
  • Edita Rutkauskaite
  • Anja Baier
  • Lars-Henrik Meyer
  • Wilhelm K Aicher
  • Andreas Drynda
  • Berno Dankbar
  • Aline Wille
  • Susanne Drynda
  • Wolfram Neumann
  • Dorothea Alexander
  • Antje Cinski
  • Maik Hoberg
  • Jochen Zwerina
  • Frank Buhling
  • Geza Pap
  • Beat A Michel
  • Michaela Weis-Klemm
  • Christian Mawrin
  • Andreas Machner
  • Matthias Pierer
  • Andreas Wunder
  • Kurt Redlich
  • Barbara Ink
  • Karin Polzer
  • Gerd Klein
  • Adrian Skwara
  • Wim van den Berg
  • Gerhard Kronke
  • Andreas Hess
  • Christina Wunrau
  • Juerg Gasser
  • Susanne Fuchs-Winkelmann
  • Clemens Scheinecker
  • Leo Joosten
  • Heidi Mendoza
  • Marvin A Peters
  • Ronald T Hay
  • Joerg Distler
  • Oskar Hoffmann
  • Noreen Pundt
  • Carsten O Tibesku
  • Katja Neugebauer
  • Lars Franssen
  • Manfred Neumann
  • Dagmar Volkmer
  • Tobias Welte
  • Paul H A Quax
  • Wolfgang König
  • Christoph Rocken
  • Olaf Wiesner
  • Joern Kekow
  • Michael Naumann
  • Yukio Shigeyama
  • Willemijn H van der Laan
  • Dorothee Reyer
  • Juliane K Franz
  • Wolfgang Zacharias
  • Ernst H K Stelzer
  • Michel Neidhart
  • Christoph Fiehn
  • Ingmar Meineckel
  • Gerd Stehle
  • Elena Neumann

Detail Information

Publications31

  1. ncbi Cyclophilins in rheumatoid arthritis--stepping into an undiscovered country?
    Thomas Pap
    Division of Molecular Medicine of Musculoskeletal Tissue, Department of Orthopaedic Surgery, University Hospital of Munster, Domagkstrasse 3, D-48129 Munster, Germany
    Clin Immunol 116:199-201. 2005
  2. ncbi Direct interaction of immunoglobulins with synovial fibroblasts: a missing link in the pathogenesis of rheumatoid arthritis?
    Thomas Pap
    Division of Molecular Medicine of Musculoskeletal Tissue, , Germany
    Arthritis Res Ther 7:44-6. 2005
  3. ncbi The role of synovial fibroblasts in mediating joint destruction in rheumatoid arthritis
    Ingmar Meinecke
    Division of Experimental Rheumatology, University Hospital Magdeburg, Leipziger Str. 44, D-39120 Magdeburg, Germany
    Curr Pharm Des 11:563-8. 2005
    ..This article will review current data and hypotheses on disease mechanisms by which fibroblasts are involved in the destruction of joints in RA...
  4. ncbi Gene transfer of tissue inhibitor of metalloproteinases-3 reverses the inhibitory effects of TNF-alpha on Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts
    Andreas Drynda
    Division of Experimental Rheumatology and Orthopedics, Institute of Microbiology, Otto von Guericke University, Magdeburg, Germany
    J Immunol 174:6524-31. 2005
    ..Thus, our findings may stimulate further studies on the therapeutic potential of gene transfer strategies with TIMP-3...
  5. ncbi Retroviral gene transfer of an antisense construct against membrane type 1 matrix metalloproteinase reduces the invasiveness of rheumatoid arthritis synovial fibroblasts
    Edita Rutkauskaite
    Otto-von-Guericke-University, Magdeburg, Germany
    Arthritis Rheum 52:2010-4. 2005
    ..05). CONCLUSION: The data demonstrate that an antisense RNA expression construct against MT1-MMP can be generated and expressed in RASFs for at least 60 days. Inhibition of MT1-MMP significantly reduces the cartilage degradation by RASFs...
  6. ncbi MAPK signalling in rheumatoid joint destruction: can we unravel the puzzle?
    Lars-Henrik Meyer
    Division of Molecular Medicine of Musculoskeletal Tissue, Department of Orthopaedics, University Hospital of Munster, Munster, Germany
    Arthritis Res Ther 7:177-8. 2005
    ..These data highlight the complexity of MAPK signalling in arthritis and provide a basis for the design of novel strategies to treat human RA...
  7. ncbi The role of mesenchymal cells in the pathophysiology of inflammatory arthritis
    Lars-Henrik Meyer
    Division of Molecular Medicine of Musculoskeletal Tissue, Department of Orthopedics, University Hospital Muenster, Domagkstrasse 3, D-48149 Munster, Germany
    Best Pract Res Clin Rheumatol 20:969-81. 2006
    ....
  8. ncbi Attachment to laminin-111 facilitates transforming growth factor beta-induced expression of matrix metalloproteinase-3 in synovial fibroblasts
    Maik Hoberg
    Department of Orthopedic Surgery, CRONA University Hospital, Tuebingen, Germany
    Ann Rheum Dis 66:446-51. 2007
    ....
  9. ncbi Hepatocyte growth factor induction of macrophage chemoattractant protein-1 and osteophyte-inducing factors in osteoarthritis
    Berno Dankbar
    Department of Orthopaedics, University Hospital of Muenster, Domagkstrasse 3, D 48149 Muenster, Germany
    J Orthop Res 25:569-77. 2007
    ..The results indicate that HGF may facilitate osteophyte development by promoting MCP-1-mediated entry of monocytes/macrophages into the OA-affected joint and/or by stimulating macrophage-derived growth factors...
  10. ncbi Modification of nuclear PML protein by SUMO-1 regulates Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts
    Ingmar Meinecke
    Department of Traumatology and Reconstructive Surgery, University Hospital Munster, D 48149 Munster, Germany
    Proc Natl Acad Sci U S A 104:5073-8. 2007
    ..Accumulation of DAXX in PML NBs by SUMO-1 may, therefore, contribute to the pathogenesis of inflammatory disorders...
  11. ncbi Gene transfer to synovial fibroblast: methods and evaluation in the SCID mouse model
    Ingmar Meinecke
    Methods Mol Med 135:393-412. 2007
    ..Finally, the SCID mouse in vivo model of rheumatoid joint destruction is described as a means of evaluating the effects of gene transfer on the invasiveness of synovial fibroblasts...
  12. ncbi Ex vivo gene transfer in the years to come
    Thomas Pap
    Division of Experimental Rheumatology, Center of Internal Medicine, University Hospital Magdeburg, Germany
    Arthritis Res 4:10-2. 2002
    ..Recent progress in this field will lead to the achievement of high transgene expression, and will facilitate the use of gene transfer in human trials...
  13. ncbi Cooperation of Ras- and c-Myc-dependent pathways in regulating the growth and invasiveness of synovial fibroblasts in rheumatoid arthritis
    Thomas Pap
    Center of Internal Medicine, University Hospital Magdeburg, Magdeburg, Germany
    Arthritis Rheum 50:2794-802. 2004
    ..To study the specific contribution of MAP kinase activator c-Raf-1 and one of its downstream transcription factors, c-Myc, to the growth and invasive behavior of rheumatoid arthritis synovial fibroblasts (RASFs)...
  14. ncbi Cells of the synovium in rheumatoid arthritis. Synovial fibroblasts
    Ulf Müller-Ladner
    Justus Liebig University Giessen, Department of Rheumatology and Clinical Immunology, Kerckhoff Clinic Bad Nauheim, Benekestrasse, D 61231 Bad Nauheim, Germany
    Arthritis Res Ther 9:223. 2007
    ....
  15. ncbi Apoptosis in rheumatoid arthritis
    Anja Baier
    Division of Experimental Rheumatology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany
    Curr Opin Rheumatol 15:274-9. 2003
    ..Current efforts are aimed at elucidating the specific role of these molecules in regulating the apoptosis of rheumatoid fibroblasts and at identifying molecular targets to interfere with altered apoptosis...
  16. ncbi The SCID mouse model: novel therapeutic targets - lessons from gene transfer
    Matthias Pierer
    WHO Collaborating Center for Molecular Biology and Novel Therapeutic Strategies for Rheumatic Diseases, Department of Rheumatology, University Hospital, Gloriastrasse 25, 8091, Zurich, Switzerland
    Springer Semin Immunopathol 25:65-78. 2003
    ..Modulation of both pathways by gene transfer approaches in the SCID mouse model is a feasible method aimed at identifying novel targets for the prevention of cartilage destruction in RA...
  17. ncbi Albumin-based drug delivery as novel therapeutic approach for rheumatoid arthritis
    Andreas Wunder
    Department of Radiochemistry and Radiopharmacology, German Cancer Research Center, Heidelberg, Germany
    J Immunol 170:4793-801. 2003
    ..In conclusion, albumin appears to be a suitable drug carrier in RA, most likely due to effects on synovial fibroblasts, which might increase therapeutic efficacy and reduce side effects of MTX...
  18. ncbi Modulation of pathways regulating both the invasiveness and apoptosis in rheumatoid arthritis synovial fibroblasts
    Thomas Pap
    Division of Experimental Rheumatology, University Hospital Magdeburg, Leipziger Str. 44, 39120 Magdeburg, Germany
    Joint Bone Spine 70:477-9. 2003
  19. ncbi Ribozymes that inhibit the production of matrix metalloproteinase 1 reduce the invasiveness of rheumatoid arthritis synovial fibroblasts
    Edita Rutkauskaite
    Otto-von-Guericke-University, University Hospital Magdeburg, Leipziger-Strasse 44, D-39120 Magdeburg, Germany
    Arthritis Rheum 50:1448-56. 2004
    ..CONCLUSION: Intracellular expression of ribozymes constitutes a feasible tool for inhibiting the production of matrix-degrading enzymes. Inhibition of MMP-1 alone results in a significant reduction of cartilage invasion by RASFs...
  20. ncbi Synovial fibroblasts from rheumatoid arthritis patients differ in their regulation of IL-16 gene activity in comparison to osteoarthritis fibroblasts
    Michaela Weis-Klemm
    Center for Orthopedic Surgery, , Germany
    Cell Physiol Biochem 14:293-300. 2004
    ..The enhanced expression of IL-16 in the synovial membrane early in RA vs OA may be associated in part with these distinct signaling responses...
  21. ncbi New insights into integrin signalling: implications for rheumatoid arthritis synovial fibroblasts
    Thomas Pap
    Division of Experimental Rheumatology, University Hospital Magdeburg, Germany, and Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, Switzerland
    Arthritis Res Ther 5:154-5. 2003
  22. ncbi TNF-induced structural joint damage is mediated by IL-1
    Jochen Zwerina
    Department of Internal Medicine III, Medical University of Vienna, A 1090 Vienna, Austria
    Proc Natl Acad Sci U S A 104:11742-7. 2007
    ..These data show that TNF-mediated cartilage damage is completely and TNF-mediated bone damage is partially dependent on IL-1, suggesting that IL-1 is a crucial mediator for inflammatory cartilage and bone degradation...
  23. ncbi Osteoclast-independent bone resorption by fibroblast-like cells
    Thomas Pap
    Division of Experimental Rheumatology, Otto von Guericke University, Magdeburg, Germany
    Arthritis Res Ther 5:R163-73. 2003
    ..These cells should therefore be considered novel therapeutic targets in the treatment of bone destructive disorders...
  24. ncbi Gene transfer as a future therapy for rheumatoid arthritis
    Ulf Müller-Ladner
    Department of Internal Medicine I, University of Regensburg, FJS Allee 11, D 93042 Regensburg, Germany
    Expert Opin Biol Ther 3:587-98. 2003
    ..Future strategies will also examine the potential of novel long-term expression vectors such as lentiviruses and cytomegalovirus (CMV)-based viruses as a basis for future clinical trials in RA...
  25. ncbi Differential effects of PDGF-BB on matrix metalloproteases and cytokine release in fibroblasts of Type 2 diabetic patients and normal controls in vitro
    Ralf Lobmann
    Department of Endocrinology and Metabolism, Magdeburg University Medical School, Magdeburg 39120, Germany
    J Diabetes Complications 20:105-12. 2006
    ..In this study, the in vitro effects of platelet-derived growth factor (PDGF)-BB on the expression of cytokines and matrix metalloproteases (MMPs) in fibroblasts of Type 2 diabetic patients and healthy controls were investigated...
  26. ncbi Higher susceptibility to Fas ligand induced apoptosis and altered modulation of cell death by tumor necrosis factor-alpha in periarticular tenocytes from patients with knee joint osteoarthritis
    Andreas Machner
    Department of Orthopedic Surgery, Otto-von-Guericke-University, Magdeburg, Germany
    Arthritis Res Ther 5:R253-61. 2003
    ..The antiapoptotic effects of TNF-alpha in OA tenocytes most likely reflect regenerative attempts and must be taken into account when anti-TNF strategies are considered for OA...
  27. ncbi Linking angiogenesis to bone destruction in arthritis
    Thomas Pap
    Arthritis Rheum 52:1346-8. 2005
  28. ncbi Altered expression of membrane-bound and soluble CD95/Fas contributes to the resistance of fibrotic lung fibroblasts to FasL induced apoptosis
    Frank Buhling
    Institute of Immunology, Otto von Guericke University, Magdeburg, Germany
    Respir Res 6:37. 2005
    ..We also analysed the effects of tumor necrosis factor-beta on FasL-induced cell death...
  29. ncbi Gene targeting: roadmap to future therapies
    Lars C Huber
    WHO Collaborating Center for Molecular Biology and Novel Therapeutic Strategies, Department of Rheumatology, University Hospital, Gloriastrasse 25, CH-8091 Zurich, Switzerland
    Curr Rheumatol Rep 6:323-5. 2004